Literature DB >> 7352737

A variant form of hypergranular promyelocytic leukemia (M3)

J M Bennett, D Catovsky, M T Daniel, G Flandrin, D A Galton, H R Gralnick, C Sultan.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 7352737     DOI： 10.7326/0003-4819-92-2-261

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Comprehensive review of adult acute myelogenous leukemia: cytomorphological, enzyme cytochemical, flow cytometric immunophenotypic, and cytogenetic findings.

Authors:  C H Dunphy
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia.

Authors:  Deepa Subramanyam; Cassandra D Belair; Keegan Q Barry-Holson; Haijiang Lin; Scott C Kogan; Emmanuelle Passegué; Robert Blelloch
Journal:  Cancer Res       Date:  2010-09-21       Impact factor: 12.701

3.  Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia.

Authors:  Hua Zhang; Xue-Qun Luo; Dan-Dan Feng; Xing-Ju Zhang; Jun Wu; Yu-Sheng Zheng; Xiao Chen; Ling Xu; Yue-Qin Chen
Journal:  Mol Cancer       Date:  2011-09-01       Impact factor: 27.401

4.  History of acute promyelocytic leukemia: a tale of endless revolution.

Authors:  Francesco Lo-Coco; Laura Cicconi
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-12-21       Impact factor: 2.576

5.  Simple, rapid and accurate molecular diagnosis of acute promyelocytic leukemia by loop mediated amplification technology.

Authors:  Orietta Spinelli; Alessandro Rambaldi; Francesca Rigo; Pamela Zanghì; Elena D'Agostini; Giulia Amicarelli; Francesco Colotta; Mariadomenica Divona; Claudia Ciardi; Francesco Lo Coco; Giulia Minnucci
Journal:  Oncoscience       Date:  2014-12-27

6.  Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-κB activation.

Authors:  Károly Jambrovics; Iván P Uray; Zsolt Keresztessy; Jeffrey W Keillor; László Fésüs; Zoltán Balajthy
Journal:  Haematologica       Date:  2018-09-20       Impact factor: 9.941
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.